What Affects Cancer Prognosis?

## What Is Prognosis? Prognosis is the expected course and outcome of a disease. In cancer, it usually refers to the likelihood of survival, recurrence, or response to treatment. Prognosis is typically expressed as: - **5-year survival rate** — percentage of patients alive 5 years after diagnosis - **Median survival** — the time at which half of patients have died and half are still alive - **Response rate** — percentage of patients whose cancer responds to a given treatment ## Key Factors That Affect Prognosis ### 1. Cancer Type Some cancers are inherently more treatable than others. Testicular cancer has >95% cure rates. Pancreatic cancer remains one of the most challenging. This reflects the biology of the cancer, not patient behavior. ### 2. Stage at Diagnosis Earlier-stage cancers — detected before they spread — generally have better prognoses. This is why screening matters. ### 3. Cancer Grade How abnormal the cells look under a microscope. Higher grade = more aggressive = generally worse prognosis for the same stage. ### 4. Molecular Profile / Biomarkers The single most important advance in oncology over the last 20 years. A cancer's genetic mutations determine: - Whether targeted therapies will work - Whether immunotherapy is likely to be effective - How aggressive the disease is likely to behave Two patients with "the same" stage 4 lung cancer may have dramatically different prognoses based on their EGFR mutation status, PD-L1 expression, and other biomarkers. ### 5. Treatment Response How well the cancer responds to initial therapy is a strong predictor of outcomes. Patients who achieve complete remission or deep partial response typically do better long-term. ### 6. Performance Status Your overall physical function. Oncologists use the **ECOG Performance Status** (0–5 scale): - 0 = Fully active, no restrictions - 1 = Restricted in physically strenuous activity but ambulatory - 2 = Ambulatory, capable of self-care, up >50% of waking hours - 3–4 = Limited self-care, largely confined to bed/chair Better performance status generally predicts better treatment tolerance and outcomes. ### 7. Age and Comorbidities Younger patients with no other health problems generally tolerate treatment better and recover faster, though this relationship is complex and many older adults do extremely well with appropriate treatment. ### 8. Access to Specialized Care Patients treated at high-volume cancer centers by specialists in their cancer type have better outcomes. This is well-documented in the data for many cancer types. ### 9. Clinical Trial Access Access to newer therapies through clinical trials can significantly change outcomes, particularly for cancers where standard therapy has limited effectiveness. ## Why Statistics Don't Predict Individual Results Survival statistics are calculated from large populations of patients — many of whom were diagnosed years ago before modern targeted therapies and immunotherapy existed. They represent an average that doesn't reflect your specific molecular profile, your access to cutting-edge treatment, or your individual biology. When an oncologist says "median survival is 18 months," they mean half of patients in past studies survived longer than 18 months. You are not the median.